Please use this identifier to cite or link to this item:
|Title:||Prevalence of Plasmodium falciparum infection among pregnant women at first antenatal visit in post-Ebola Monrovia, Liberia|
|Author:||Martínez Pérez, Guillermo|
Lansana, Dawoh Peter
Goteh, James D. K.
Kercula, Juwe D.
Kibungu, Fanta D.
Meyer García-Sípido, Ana
Bassat Orellana, Quique
Tarr-Attia, Christine K.
Mayor Aparicio, Alfredo Gabriel
|Abstract:||Background: Disruption of malaria control strategies during the West African 2014–2016 Ebola epidemic led to an increase in malaria-attributable mortality. However, recent data on malaria infection in vulnerable groups, such as pregnant women, are lacking in this post-Ebola scenario. This cross-sectional study aimed to assess the prevalence of Plasmodium falciparum infection and of molecular markers of drug resistance among pregnant women attending antenatal care in Monrovia, capital of Liberia. Methods: From October 2016 to June 2017, all pregnant women attending their frst antenatal care visit at the Saint Joseph’s Catholic Hospital, Monrovia, were invited to participate in the study. In addition to their routine antenatal care tests, capillary blood spotted onto flter papers were collected from all consenting participants to determine presence of P. falciparum by real-time quantitative PCR. Molecular markers of anti-malarial drug resistance were assessed through Sanger sequencing and quantitative PCR in specimens positive for P. falciparum analysis. Results: Of the 195 women participants, 24 (12.3%) were P. falciparum-positive by qPCR. Infected women tended to be more commonly primigravidae and younger than uninfected ones. Parasite densities were higher in primigravidae. Fever was more frequently detected among the infected women. No statistically signifcant association between P. falciparum infection and haemoglobin levels or insecticide-treated net use was found. While high prevalence of genetic polymorphisms associated with chloroquine and amodiaquine resistance were detected, no molecular markers of artemisinin resistance were observed. Conclusion: Plasmodium falciparum infections are expected to occur in at least one in every eight women attending frst ANC at private clinics in Monrovia and outside the peak of the rainy season. Young primigravidae are at increased risk of P. falciparum infection. Molecular analyses did not provide evidence of resistance to artemisinins among the P. falciparum isolates tested. Further epidemiological studies involving pregnant women are necessary to describe the risk of malaria in this highly susceptible group outside Monrovia, as well as to closely monitor the emergence of resist‑ ance to anti-malarials, as recommended by the Liberian National Malaria Control Programme.|
|Note:||Reproducció del document publicat a: http://dx.doi.org/ 10.1186/s12936-018-2506-z|
|It is part of:||Malaria Journal, 2018, vol. 17, num. 357|
|Related resource:||http://dx.doi.org/ 10.1186/s12936-018-2506-z|
|Appears in Collections:||Articles publicats en revistes (ISGlobal)|
Files in This Item:
|Mart_nez-Perez_G_Malar_J_2018.pdf||952.5 kB||Adobe PDF||View/Open|
This item is licensed under a Creative Commons License